title: Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment.
abstract: Chromogranin A (CHGA/Chga) has been implicated in the genesis of systemic hypertension and consequent cardiac abnormalities. Catestatin (CST) (human CHGA(352-372)) replacement reduces blood pressure elevation and increases baroreflex sensitivity in Chga knockout (KO) mice. Because of the dampened baroreflex sensitivity, we reasoned that KO mice would display altered heart rate variability (HRV). Thus, we evaluated beat-to-beat measurements in HRV in wild-type (WT) and KO mice, before and after CST replacement. HR dynamics were evaluated by bipolar Einthoven electrocardiogram, with deconvolution into time and frequency domains, as well as Lorenz nonlinear return analyses. At baseline, HR was higher [444 +/- 24 beats per minute (bpm)] in KO compared with WT (330 +/- 18 bpm) mice. The total power in the HRV spectra was substantially diminished in KO animals. CST increased total power but only in KO mice. Each time-domain parameter was substantially lower in KO compared with WT mice, and the CST in the KO group could reverse the differences. Lorenz analysis revealed reductions in S1 (short axis perpendicular to the line of identity in the ellipse) and S2 (long axis along the line of identity in the ellipse) in KO animals, indicating that regulation of HRV is diminished in the parasympathetic and sympathetic domains. CST replacement caused restoration of both S1 and S2, in the KO group. These data suggest that Chga has a profound effect on autonomic tone to the heart and that its CST fragment is responsible for such actions. The results suggest future strategies for intervention in cardiovascular disorders accompanied by adverse HRV profiles.
authors.affiliation: Department of Medicine (0838), University of California, San Diego, and Veterans Affairs San Diego Healthcare System, 9500 Gilman Drive, La Jolla, California 92093-0838, USA.
authors.forename: Nagendu B
authors.initials: NB
authors.lastname: Dev
authors.forename: Jiaur R
authors.initials: JR
authors.lastname: Gayen
authors.forename: Daniel T
authors.initials: DT
authors.lastname: O'Connor
authors.forename: Sushil K
authors.initials: SK
authors.lastname: Mahata
mesh_terms: D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects* / Q000378:metabolism; D053379:Chromogranin A / Q000235:genetics / Q000494:pharmacology* / Q000502:physiology*; D004594:Electrophysiology; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010446:Peptide Fragments / Q000494:pharmacology*
chemical_list: D053379:Chromogranin A; D010446:Peptide Fragments; C109084:chromogranin A (344-364)
references.citation: Acta Physiol (Oxf). 2008 Feb;192(2):309-24
references.pmid: 18005393
references.citation: Endocrinology. 2009 Nov;150(11):5027-35
references.pmid: 19819970
references.citation: Curr Protein Pept Sci. 2003 Apr;4(2):97-104
references.pmid: 12678849
references.citation: Masui. 2006 Apr;55(4):436-40
references.pmid: 16634545
references.citation: J Clin Invest. 1997 Sep 15;100(6):1623-33
references.pmid: 9294131
references.citation: Circ Res. 1998 Mar 9;82(4):416-23
references.pmid: 9506701
references.citation: J Biol Chem. 2009 Oct 16;284(42):28498-509
references.pmid: 19706599
references.citation: Physiol Meas. 2002 Nov;23(4):671-82
references.pmid: 12450268
references.citation: Mol Pharmacol. 2004 Nov;66(5):1180-91
references.pmid: 15326220
references.citation: Arch Mal Coeur Vaiss. 2003 Oct;96(10):955-62
references.pmid: 14653055
references.citation: Ann Intern Med. 1980 Feb;92(2 Pt 2):304-7
references.pmid: 7356218
references.citation: J Hypertens Suppl. 1984 Dec;2(3):S147-50
references.pmid: 6599663
references.citation: Cardiovasc Res. 2008 Aug 1;79(3):527-36
references.pmid: 18349137
references.citation: Am J Hum Genet. 2004 Feb;74(2):197-207
references.pmid: 14740315
references.citation: Biomed Eng Online. 2009 Jan 29;8:3
references.pmid: 19178728
references.citation: Q J Med. 1980 Winter;49(193):95-108
references.pmid: 7433630
references.citation: Nat Biotechnol. 2009 Jun;27(6):567-71
references.pmid: 19448630
references.citation: J Clin Invest. 2005 Jul;115(7):1942-52
references.pmid: 16007257
references.citation: Eur Heart J. 2002 Jun;23(12):967-74
references.pmid: 12069452
references.citation: Kidney Int. 2008 Jul;74(1):115-25
references.pmid: 18432188
references.citation: Endocrinology. 2008 Oct;149(10):4780-93
references.pmid: 18535098
references.citation: Mol Endocrinol. 2000 Oct;14(10):1525-35
references.pmid: 11043569
references.citation: Am J Cardiol. 1997 Jun 15;79(12):1645-50
references.pmid: 9202356
references.citation: Diabetes. 1982 Apr;31(4 Pt 1):339-45
references.pmid: 7152130
references.citation: Hypertension. 1998 Aug;32(2):293-7
references.pmid: 9719057
references.citation: Stroke. 2003 Oct;34(10):2446-50
references.pmid: 12958326
references.citation: J Auton Pharmacol. 1994 Jun;14(3):187-200
references.pmid: 7929473
references.citation: J Am Coll Cardiol. 2001 Jun 15;37(8):2136-43
references.pmid: 11419900
references.citation: Kidney Int. 1990 Mar;37(3):955-64
references.pmid: 2313983
references.citation: Am J Cardiol. 1987 Feb 1;59(4):256-62
references.pmid: 3812275
references.citation: Circulation. 1996 Mar 1;93(5):1043-65
references.pmid: 8598068
references.citation: Regul Pept. 1992 Sep 3;41(1):9-18
references.pmid: 1455014
references.citation: Circulation. 2007 May 1;115(17):2271-81
references.pmid: 17438154
references.citation: Am J Cardiol. 2000 Aug 1;86(3):309-12
references.pmid: 10922439
references.citation: J Hypertens. 2002 Jul;20(7):1335-45
references.pmid: 12131530
references.citation: Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H113-22
references.pmid: 18469147
references.citation: Int J Cardiol. 2009 Aug 14;136(2):211-3
references.pmid: 18606470
references.citation: Hypertension. 1990 Mar;15(3):237-46
references.pmid: 2406199
references.citation: Immunopharmacology. 1999 Dec;45(1-3):21-7
references.pmid: 10614985
references.citation: N Engl J Med. 2003 Mar 20;348(12):1134-49
references.pmid: 12646671
references.citation: Ann Noninvasive Electrocardiol. 2006 Apr;11(2):154-62
references.pmid: 16630090
references.citation: Peptides. 2008 Nov;29(11):1943-52
references.pmid: 18638516
references.citation: Peptides. 1998;19(7):1241-8
references.pmid: 9786174
references.citation: Curr Atheroscler Rep. 2002 Mar;4(2):120-7
references.pmid: 11822975
references.citation: Neuroscience. 1992 Aug;49(3):497-528
references.pmid: 1501763
references.citation: Int J Cardiol. 1996 Mar;53(3):291-8
references.pmid: 8793584
references.citation: Circulation. 1995 Apr 1;91(7):1936-43
references.pmid: 7895350
references.citation: Am J Physiol Heart Circ Physiol. 2000 Aug;279(2):H733-40
references.pmid: 10924073
references.citation: Am J Cardiol. 1989 Nov 15;64(18):1162-7
references.pmid: 2816768